EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS

The article presents the results of a study of effectiveness and safety of infliximab — monoclonal antibodies to tumor necrotizing factor (TNF) _ in treatment of 47 patients in age 11 months — 16 years old with early pauciarticular and polyarticular types of juvenile rheumatoid arthritis. The durati...

Full description

Bibliographic Details
Main Authors: E.I. Alexeeva, T.V. Sleptsova, S.I. Valieva, T.M. Bzarova, R.V. Denisova, A.O. Lisitsin, E.Yu. Gudkova, A.M. Chomakhidze, K.B. Isaeva, A.A. Grigor’eva, O.L. Lomakina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2009-07-01
Series:Voprosy Sovremennoj Pediatrii
Online Access:https://vsp.spr-journal.ru/jour/article/view/1142